Non-Myeloablative Allogeneic Transplantation

Nonfiction, Health & Well Being, Medical, Specialties, Oncology, Surgery
Cover of the book Non-Myeloablative Allogeneic Transplantation by , Springer US
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9781461509196
Publisher: Springer US Publication: December 6, 2012
Imprint: Springer Language: English
Author:
ISBN: 9781461509196
Publisher: Springer US
Publication: December 6, 2012
Imprint: Springer
Language: English

Non-myeloablative allogeneic stem cell transplantation (also known as mini-transplantation or reduced-intensity conditioning transplantation) is a major advance in the field of hematopoietic transplantation within the last 5 years. This approach uses non-cytotoxic or reduced-intensity cytotoxic therapy to prepare patients for allografting of hematopoietic stem cells and lymphocytes. It has the potential to deliver the potent anti-tumor immunotherapy and bone marrow replacement capacity of allogeneic stem cell transplantation to patients with reduced treatment-related morbidity and mortality. It may also enable allogeneic transplantation in patients who would be considered ineligible for conventional transplants because of co-morbidity or advanced age. However, this approach may necessitate more careful monitoring of post-transplant chimerism and malignant disease-status than is usual with conventional allografting. There is also controversy regarding the best preparative regimen and graft-versus-host disease prophylaxis to use.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Non-myeloablative allogeneic stem cell transplantation (also known as mini-transplantation or reduced-intensity conditioning transplantation) is a major advance in the field of hematopoietic transplantation within the last 5 years. This approach uses non-cytotoxic or reduced-intensity cytotoxic therapy to prepare patients for allografting of hematopoietic stem cells and lymphocytes. It has the potential to deliver the potent anti-tumor immunotherapy and bone marrow replacement capacity of allogeneic stem cell transplantation to patients with reduced treatment-related morbidity and mortality. It may also enable allogeneic transplantation in patients who would be considered ineligible for conventional transplants because of co-morbidity or advanced age. However, this approach may necessitate more careful monitoring of post-transplant chimerism and malignant disease-status than is usual with conventional allografting. There is also controversy regarding the best preparative regimen and graft-versus-host disease prophylaxis to use.

More books from Springer US

Cover of the book Coronary flow reserve - measurement and application: Focus on transthoracic Doppler echocardiography by
Cover of the book Engine Emissions by
Cover of the book Health Effects of Ambient Air Pollution by
Cover of the book Reminiscence, Motivation, and Personality by
Cover of the book Biological Energy Conservation by
Cover of the book Labour Law and Industrial Relations in Japan by
Cover of the book Engineering IT-Enabled Sustainable Electricity Services by
Cover of the book Self-Esteem by
Cover of the book Down Syndrome by
Cover of the book The Generation of High Magnetic Fields by
Cover of the book The Unknown Component Problem by
Cover of the book New Directions in Lemur Studies by
Cover of the book The Smallest Anthropoids by
Cover of the book Placental Vascularization and Blood Flow by
Cover of the book The Chemistry of Mood, Motivation, and Memory by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy